Free Trial

NeuroPace (NPCE) Competitors

NeuroPace logo
$7.80 +0.81 (+11.59%)
(As of 11/6/2024 ET)

NPCE vs. UTMD, SMTI, TELA, CVRX, XAIR, KIDS, IRMD, AXGN, SIBN, and FNA

Should you be buying NeuroPace stock or one of its competitors? The main competitors of NeuroPace include Utah Medical Products (UTMD), Sanara MedTech (SMTI), TELA Bio (TELA), CVRx (CVRX), Beyond Air (XAIR), OrthoPediatrics (KIDS), Iradimed (IRMD), AxoGen (AXGN), SI-BONE (SIBN), and Paragon 28 (FNA). These companies are all part of the "medical" sector.

NeuroPace vs.

Utah Medical Products (NASDAQ:UTMD) and NeuroPace (NASDAQ:NPCE) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Utah Medical Products received 127 more outperform votes than NeuroPace when rated by MarketBeat users. Likewise, 61.45% of users gave Utah Medical Products an outperform vote while only 56.52% of users gave NeuroPace an outperform vote.

CompanyUnderperformOutperform
Utah Medical ProductsOutperform Votes
153
61.45%
Underperform Votes
96
38.55%
NeuroPaceOutperform Votes
26
56.52%
Underperform Votes
20
43.48%

Utah Medical Products has higher earnings, but lower revenue than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Utah Medical Products$50.22M4.65$16.64M$4.2715.73
NeuroPace$65.42M3.48-$32.96M-$1.09-7.16

Utah Medical Products has a net margin of 34.62% compared to NeuroPace's net margin of -41.63%. Utah Medical Products' return on equity of 12.04% beat NeuroPace's return on equity.

Company Net Margins Return on Equity Return on Assets
Utah Medical Products34.62% 12.04% 11.42%
NeuroPace -41.63%-195.26%-29.88%

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 6.6% of Utah Medical Products shares are owned by company insiders. Comparatively, 22.2% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Utah Medical Products has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500. Comparatively, NeuroPace has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500.

In the previous week, Utah Medical Products had 1 more articles in the media than NeuroPace. MarketBeat recorded 5 mentions for Utah Medical Products and 4 mentions for NeuroPace. Utah Medical Products' average media sentiment score of 0.74 beat NeuroPace's score of 0.46 indicating that Utah Medical Products is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Utah Medical Products
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NeuroPace
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NeuroPace has a consensus target price of $15.00, suggesting a potential upside of 92.31%. Given NeuroPace's stronger consensus rating and higher probable upside, analysts clearly believe NeuroPace is more favorable than Utah Medical Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Utah Medical Products
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NeuroPace
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

Utah Medical Products beats NeuroPace on 11 of the 18 factors compared between the two stocks.

Get NeuroPace News Delivered to You Automatically

Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NPCE vs. The Competition

MetricNeuroPaceSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$227.76M$4.43B$5.30B$8.76B
Dividend YieldN/A42.37%5.19%4.03%
P/E Ratio-7.1628.19101.4416.55
Price / Sales3.4863.30677.09104.43
Price / CashN/A49.9235.0731.67
Price / Book9.874.734.735.23
Net Income-$32.96M$12.14M$115.11M$224.13M
7 Day Performance20.93%5.34%3.29%3.73%
1 Month Performance16.77%8.65%9.13%6.93%
1 Year Performance10.33%46.00%37.82%27.75%

NeuroPace Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NPCE
NeuroPace
3.3674 of 5 stars
$7.80
+11.6%
$15.00
+92.3%
+8.3%$227.76M$65.42M-7.16170Upcoming Earnings
UTMD
Utah Medical Products
3.9573 of 5 stars
$64.64
+0.9%
N/A-16.1%$224.95M$50.22M15.14180News Coverage
SMTI
Sanara MedTech
2.1355 of 5 stars
$33.45
-0.2%
N/A+31.4%$292.69M$64.99M-42.8860Upcoming Earnings
TELA
TELA Bio
3.1199 of 5 stars
$2.85
-1.7%
N/A-45.9%$70.44M$64.74M-1.66120Gap Up
CVRX
CVRx
1.9113 of 5 stars
$15.05
+12.3%
N/A-9.1%$327.88M$47.26M-5.57200Analyst Forecast
High Trading Volume
XAIR
Beyond Air
4.6422 of 5 stars
$0.48
-2.0%
N/A-77.0%$22.66M$1.16M-0.2970Upcoming Earnings
KIDS
OrthoPediatrics
4.495 of 5 stars
$28.74
+5.0%
N/A+12.9%$695.80M$148.73M-26.37200News Coverage
Gap Up
IRMD
Iradimed
4.7232 of 5 stars
$49.36
+2.2%
N/A+32.4%$625.39M$65.56M33.81110Dividend Announcement
Gap Up
AXGN
AxoGen
1.0381 of 5 stars
$14.20
+1.8%
N/A+290.1%$622.39M$159.01M-37.37426Upcoming Earnings
Gap Up
SIBN
SI-BONE
4.1924 of 5 stars
$13.63
+1.0%
N/A-8.2%$568.24M$138.89M-13.50350Upcoming Earnings
Gap Up
FNA
Paragon 28
2.4331 of 5 stars
$6.06
+7.8%
N/A-26.8%$506.27M$235.44M-8.78343,000Upcoming Earnings
Gap Up

Related Companies and Tools


This page (NASDAQ:NPCE) was last updated on 11/7/2024 by MarketBeat.com Staff
From Our Partners